News archive

Q4 2022 Report and Nomination Committee

February 28, 2023
Q4 2022 Report  Lifecare AS will present Q4 2022 Report on Tuesday 28 February. The webcast will be for all shareholders and interested parties at 12:30 – 13:15 CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be a Q&A session following the presentation. The webcast will be available here: Link to Teams meeting […]
Read more

Important week for Lifecare in Berlin at the 16th international conference on Advanced Technologies & Treatments for Diabetes (ATTD)

February 22, 2023
The upcoming days Lifecare will be productive and important for Lifecare in in Berlin where two presentations will be held at the prestigious conference ATTD. The company will also attend the steering committee of the FORGETDIABETES consortium.     PRESENTATIONS AT ATTD IN BERLIN  In the next days, Lifecare will participate at the 16th International Conference […]
Read more

Sensor longevity breakthrough in Lifecare

February 6, 2023
Ongoing clinical development study confirms Lifecare’s expectation of a sensor longevity that far exceeds the lifetime of existing and commercially available needle sensors for glucose monitoring.   CSO Prof. Andreas Pfützner and CEO Joacim Holter   Today Lifecare can report that sensors used in a three-day clinical study continue to work in an in vitro […]
Read more

Information from Lifecare January 2023

January 26, 2023
New collaboration strengthens Lifecare’s development Lifecare recently entered into a partnership with Goethe University Frankfurt am Main.   – Complementary expertise, further strengthening of our product development as well as strengthening our potential recruitment base were decisive for the new agreement with a professionally strong research environment, says CEO Joacim Holter. CEO Joacim Holter and CSO […]
Read more

Happy New Year

January 5, 2023
2022 was a very good year for Lifecare as a company and we welcome 2023 expecting continued significant progress in our mission to make life easier for patients with diabetes.    Joacim Holter, CEO at Lifecare    Throughout 2022 Lifecare reached several milestone events:     In June, Lifecare disclosed the by far most important development events […]
Read more

Lifecare Q3 2022: All-time high revenue

December 6, 2022
Lifecare announces all-time high revenue in their financial reporting for Q3 2022. – We are pleased to see a positive outcome of the investments we have made. Furthermore, this provides a base for Lifecare´s continued research and product development, says CEO Joacim Holter.    Joacim Holter, CEO at Lifecare   The consolidated group financials show […]
Read more

Information from Lifecare – November 2022

December 1, 2022
Q3 financial and operational update Lifecare AS will present Q3 2022 financial and operational status on Tuesday 6 December.   The webcast will be for all shareholders and interested parties at 13:00 – 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be a Q&A session following the presentation. The webcast will be available […]
Read more

Lifecare launching new company in UK

November 8, 2022
Lifecare has incorporated a new subsidiary, Lifecare Chemistry Ltd, located in Bath, UK. – This move gives us clear strategic advantages related to chemical research development and builds on the close and good collaboration Lifecare already has established with the University of Bath, says CEO Joacim Holter.   Photo caption: Left to right: Jordan Gardiner, […]
Read more

Information from Lifecare – October 2022

October 7, 2022
Business presentation at LSX 2022 The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region and took place in Copenhagen in September. – We register an increasing interest for the company on the Nordic investor scene, states CEO Joacim Holter.   – After a long period of pandemic, […]
Read more

Information from Lifecare – September 2022

October 4, 2022
Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations. Conducting clinical trials on humans is a significant step towards Lifecare’s goal of contributing to helping people with diabetes to live a normal life.     The purpose of the first study is to optimize signal reading from the […]
Read more